Back to Search
PAUL T. EMERY M.D.
M.D.
Internal Medicine Physician
NPI: 1194798215Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
6387(NV)
Research & Publications (20)
Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study.
PMID 19433410·Ann Rheum Dis·2010
4-observational
The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy.
PMID 19666937·Ann Rheum Dis·2010
8-other
A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools.
PMID 19359260·Ann Rheum Dis·2010
8-other
PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.
PMID 19470526·Ann Rheum Dis·2010
1-meta
Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008.
PMID 19389716·Ann Rheum Dis·2010
8-other
Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level.
PMID 19346219·Ann Rheum Dis·2010
8-other
Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study.
PMID 19435719·Ann Rheum Dis·2010
1-meta
Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy.
PMID 19357113·Ann Rheum Dis·2010
4-observational
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial.
PMID 19293160·Ann Rheum Dis·2010
2-rct
Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis.
PMID 19369462·J Rheumatol·2009
3-trial
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies.
PMID 18388156·Ann Rheum Dis·2009
3-trial
Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes.
PMID 19359276·Hum Mol Genet·2009
4-observational
Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis.
PMID 19366897·Ann Rheum Dis·2009
2-rct
Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study.
PMID 19386610·Ann Rheum Dis·2009
2-rct
The effect of protein malnutrition on the capacity for protein synthesis during wound healing.
PMID 19390746·J Nutr Health Aging·2009
7-preclinical
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal.
PMID 19297345·Ann Rheum Dis·2009
4-observational
Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study.
PMID 19273451·J Rheumatol·2009
3-trial
Costimulation blockade in rheumatic diseases: where we are?
PMID 19342956·Curr Opin Rheumatol·2009
6-review
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients.
PMID 19155233·Ann Rheum Dis·2009
8-other
Adaptation and cross-cultural validation of the rheumatoid arthritis work instability scale (RA-WIS).
PMID 19074912·Ann Rheum Dis·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4015 S BUFFALO DR STE 1
LAS VEGAS, NV 89147 - Phone
- (725) 293-4602
Quick Facts
- NPI
- 1194798215
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile